Cardiac tumors surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(7 intermediate revisions by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Cardiac tumors}}
{{Cardiac tumors}}
{{CMG}}; {{AE}} {{Dj}}
{{CMG}}; {{AE}} {{DMakkar}}
==Overview==
==Overview==
__NOTOC__
{{Cardiac tumors}}
{{CMG}}; {{AE}} {{Dj}}
Surgery may be an option in specific cases of malignant tumors.  
Surgery may be an option in specific cases of malignant tumors.  
*Patients with solitary heart illness and a managed primary tumor are optimal.  
*Patients with solitary heart illness and a managed primary tumor are optimal.  
Line 12: Line 8:


==Surgery==
==Surgery==
__NOTOC__
 
{{Cardiac tumors}}
{{CMG}}; {{AE}} {{Dj}}
Whether malignant or benign, clinical signs determine the criteria for emergency surgery.
Whether malignant or benign, clinical signs determine the criteria for emergency surgery.
*Cardiac tumors can generate a wide range of symptoms, including the four indications for surgery:  
*Cardiac tumors can generate a wide range of symptoms, including the four '''indications for surgery''':  
**Restriction of intracardiac blood circulation or interference with valve function
**'''Restriction of intracardiac blood circulation''' or interference with valve function
**Rhythm abnormalities or pericardial effusions with tamponade owing to local penetration
**'''Rhythm abnormalities''' or '''pericardial effusions''' with tamponade owing to local penetration
**Embolization, resulting in systemic or pulmonary impairments
**'''Embolization''', resulting in systemic or pulmonary impairments
**Systemic or constitutional symptoms resulting from the tumors
**'''Systemic or constitutional symptoms''' resulting from the tumors
{| class="wikitable"
|+ Surgical Treatment of Cardiac Tumors
|-
! Tumor !! Treatment
|-
|  '''[[Myxoma]]''' ||  Total excision
**Surgical intervention is necessary for patients with '''severe dyspnea or a significant risk of embolism'''.
**'''Surgical mortality rate''' of less than 5%
**2% to 5% of patients are at '''risk for recurrence<ref name="pmid22447042">{{cite journal| author=Lamba G, Frishman WH| title=Cardiac and pericardial tumors. | journal=Cardiol Rev | year= 2012 | volume= 20 | issue= 5 | pages= 237-52 | pmid=22447042 | doi=10.1097/CRD.0b013e31825603e7 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22447042  }} </ref>
'''
|-
|'''[[Papillary Fibroelastomas]]'''  || Surgical resection with reconstruction,
*Less often, valve replacement. <ref name="pmid22447042">{{cite journal| author=Lamba G, Frishman WH| title=Cardiac and pericardial tumors. | journal=Cardiol Rev | year= 2012 | volume= 20 | issue= 5 | pages= 237-52 | pmid=22447042 | doi=10.1097/CRD.0b013e31825603e7 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22447042  }} </ref>
 
|-
| '''[[Cardiac Rhabdomyoma]]''' || Therapeutic resection of the problem portion of the lesion<ref name="pmid22447042">{{cite journal| author=Lamba G, Frishman WH| title=Cardiac and pericardial tumors. | journal=Cardiol Rev | year= 2012 | volume= 20 | issue= 5 | pages= 237-52 | pmid=22447042 | doi=10.1097/CRD.0b013e31825603e7 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22447042  }} </ref>
|-
| '''[[Cardiac Fibroma]]''' || Complete excision/ Palliative partial resection<ref name="pmid22447042">{{cite journal| author=Lamba G, Frishman WH| title=Cardiac and pericardial tumors. | journal=Cardiol Rev | year= 2012 | volume= 20 | issue= 5 | pages= 237-52 | pmid=22447042 | doi=10.1097/CRD.0b013e31825603e7 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22447042  }} </ref>
|-
| '''[[Teratoma]]''' || Fetal Tumor Excision or Immediate surgery after Cesarian section<ref name="pmid22447042">{{cite journal| author=Lamba G, Frishman WH| title=Cardiac and pericardial tumors. | journal=Cardiol Rev | year= 2012 | volume= 20 | issue= 5 | pages= 237-52 | pmid=22447042 | doi=10.1097/CRD.0b013e31825603e7 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22447042  }} </ref>
|-
| '''[[Cardiac Lipoma]]''' || Complete Tumor resection<ref name="pmid22447042">{{cite journal| author=Lamba G, Frishman WH| title=Cardiac and pericardial tumors. | journal=Cardiol Rev | year= 2012 | volume= 20 | issue= 5 | pages= 237-52 | pmid=22447042 | doi=10.1097/CRD.0b013e31825603e7 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22447042  }} </ref>
|-
| '''[[Hemangioma]]''' || Conservative in asymptomatic
*Radical Resection in symptomatic<ref name="pmid22447042">{{cite journal| author=Lamba G, Frishman WH| title=Cardiac and pericardial tumors. | journal=Cardiol Rev | year= 2012 | volume= 20 | issue= 5 | pages= 237-52 | pmid=22447042 | doi=10.1097/CRD.0b013e31825603e7 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22447042  }} </ref>
|-
| '''[[Hamartomas]]''' || Surgical Resection<ref name="pmid22447042">{{cite journal| author=Lamba G, Frishman WH| title=Cardiac and pericardial tumors. | journal=Cardiol Rev | year= 2012 | volume= 20 | issue= 5 | pages= 237-52 | pmid=22447042 | doi=10.1097/CRD.0b013e31825603e7 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22447042  }} </ref>
|}


'''Papillary Fibroelastoma'''
'''Papillary Fibroelastoma'''
Line 34: Line 56:
{{WS}}
{{WS}}


[[Category:Needs content]]
[[Category:needs english review]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Cardiology]]
[[Category:Cardiology]]

Latest revision as of 20:22, 4 July 2022

Cardiac tumors Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cardiac Tumors from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cardiac tumors surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cardiac tumors surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiac tumors surgery

CDC on Cardiac tumors surgery

Cardiac tumors surgery in the news

Blogs on Cardiac tumors surgery

Directions to Hospitals Treating Cardiac tumors

Risk calculators and risk factors for Cardiac tumors surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dheeraj Makkar, M.D.[2]

Overview

Surgery may be an option in specific cases of malignant tumors.

  • Patients with solitary heart illness and a managed primary tumor are optimal.
  • The tumor must be amenable to resection while maintaining adequate heart function to support life.

Surgery

Whether malignant or benign, clinical signs determine the criteria for emergency surgery.

  • Cardiac tumors can generate a wide range of symptoms, including the four indications for surgery:
    • Restriction of intracardiac blood circulation or interference with valve function
    • Rhythm abnormalities or pericardial effusions with tamponade owing to local penetration
    • Embolization, resulting in systemic or pulmonary impairments
    • Systemic or constitutional symptoms resulting from the tumors
Surgical Treatment of Cardiac Tumors
Tumor Treatment
Myxoma Total excision
    • Surgical intervention is necessary for patients with severe dyspnea or a significant risk of embolism.
    • Surgical mortality rate of less than 5%
    • 2% to 5% of patients are at risk for recurrence[1]

Papillary Fibroelastomas Surgical resection with reconstruction,
  • Less often, valve replacement. [1]
Cardiac Rhabdomyoma Therapeutic resection of the problem portion of the lesion[1]
Cardiac Fibroma Complete excision/ Palliative partial resection[1]
Teratoma Fetal Tumor Excision or Immediate surgery after Cesarian section[1]
Cardiac Lipoma Complete Tumor resection[1]
Hemangioma Conservative in asymptomatic
  • Radical Resection in symptomatic[1]
Hamartomas Surgical Resection[1]

Papillary Fibroelastoma

  • Surgery is the mainstay of therapy for papillary fibroelastoma.
  • Surgical excision is generally recommended among patients with papillary fibroelastoma (for symptomatic relief).
  • A minimally invasive approach may be possible if the tumor involves the aortic valveor right atrium.[2]
  • In the case of aortic valve involvement, excision of the tumor is often valve-sparing, meaning that replacement of the valve with a prosthetic valve is not necessary. Repair of the native valve with a pericardial patch has been described.[3]

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 Lamba G, Frishman WH (2012). "Cardiac and pericardial tumors". Cardiol Rev. 20 (5): 237–52. doi:10.1097/CRD.0b013e31825603e7. PMID 22447042.
  2. Kim RW, Jeffery ME, Smith MJ, Wilensky RL, Woo EY, Woo YJ. (2007). "Minimally invasive resection of papillary fibroelastoma in a high-risk patient". J Cardiovasc Med (Hagerstown). 8 (8): 639–41. PMID 17667039.
  3. Westhof FB, Chryssagis K, Liangos A, Batz G, Diegeler A. (2007). "Aortic valve leaflet reconstruction after excision of a papillary fibroelastoma using autologous pericardium". Thorac Cardiovasc Surg. 55 (3): 204–7. PMID 17410513.

Template:WH Template:WS